CREG调控脓毒症诱导ARDS肺泡巨噬细胞自噬与极化及其临床价值
该研究包含细胞实验与前瞻性病例对照两部分。细胞实验中,LPS刺激降低RAW264.7来源肺泡巨噬细胞Beclin1、LC3-II/LC3-I比值及CD206,升高p62和CD86;CREG过表达可改善上述自噬与极化指标,CREG干扰则进一步恶化。临床部分纳入脓毒症并发ARDS 40例、脓毒症无ARDS 60例及健康对照20例,发现ARDS组PaO2/FiO2和CREG更低、炎症指标更高;多因素Logistic回归显示CREG升高为保护因素(OR=0.385,95%CI 0.344-0.432,P=0.015),ROC曲线AUC为0.806(95%CI 0.713-0.899),cut-off 7.85 μg/L时敏感度71.43%、特异度78.57%。
要点
- 脓毒症并发ARDS患者血清CREG水平低于脓毒症无ARDS患者,且随APACHE II评分升高而进行性下降。
- 血清CREG预测脓毒症并发ARDS的ROC曲线AUC为0.806(95%CI 0.713-0.899),最佳cut-off值7.85 μg/L,敏感度71.43%,特异度78.57%。
- 多因素Logistic回归显示CREG升高为脓毒症并发ARDS的独立保护因素(OR=0.385,95%CI 0.344-0.432,P=0.015)。
- 细胞实验中CREG过表达可上调Beclin1、LC3-II/LC3-I比值及CD206,降低p62和CD86,即增强自噬并纠正M1/M2极化失衡。
- APACHE II评分升高和炎症标志物(IL-6、TNF-α、PCT、CRP)升高是脓毒症并发ARDS的独立危险因素(均OR>1,均P<0.05)。
适用人群与场景
- 细胞实验:小鼠单核/巨噬细胞系RAW264.7诱导分化的肺泡巨噬细胞。
诊断标准与关键阈值
- 脓毒症并发ARDS判定:入组后72小时内发生ARDS。
- 血清CREG预测脓毒症并发ARDS的最佳cut-off值为7.85 μg/L,此时敏感度71.43%、特异度78.57%。
- APACHE II评分用于评估病情严重程度,评分越高血清CREG越低、炎症标志物越高。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:细胞实验+前瞻性病例对照研究;临床部分单中心,纳入脓毒症并发ARDS 40例、脓毒症无ARDS 60例、健康对照20例。
- 细胞实验:与空白对照组比较,LPS组Beclin1(0.32±0.05 vs. 0.87±0.09)、LC3-II/LC3-I比值(0.41±0.06 vs. 1.24±0.11)、CD206[(27.14±3.52)% vs.(51.78±5.91)%]降低,p62(1.58±0.13 vs. 0.53±0.07)和CD86[(38.35±4.67)% vs.(18.26±3.24)%]升高,均P<0.05;CREG过表达改善上述指标
- 临床结果:脓毒症并发ARDS组较脓毒症无ARDS组PaO2/FiO2和CREG更低、炎症标志物更高(均P<0.05);三组性别、年龄无显著差异(均P>0.05),两脓毒症组感染部位分布无显著差异(P>0.05)。
- 多因素Logistic回归:APACHE II评分升高和炎症标志物升高为脓毒症并发ARDS独立危险因素(均OR>1,均P<0.05);CREG升高为保护因素(OR=0.385,95%CI 0.344-0.432,P=0.015)。
- ROC曲线:CREG预测脓毒症并发ARDS的AUC为0.806(95%CI 0.713-0.899)。
证据类型、等级与局限
- 证据类型:细胞实验+单中心前瞻性病例对照研究。
- 局限:样本量较小(ARDS组40例、无ARDS组60例、健康对照20例),单中心,CREG预测价值需外部验证;细胞实验为体外模型。
对床旁实践的改变
- 血清CREG可能作为脓毒症患者早期识别ARDS风险的候选生物标志物,cut-off 7.85 μg/L时AUC 0.806,但需结合APACHE II评分和炎症标志物综合判断。
- CREG过表达在细胞层面改善肺泡巨噬细胞自噬和M1/M2极化,提示其作为治疗靶点的潜在价值,但尚未进入临床验证。
- 不适用于将CREG作为唯一决策指标;不能据细胞实验推断临床用药剂量或疗程。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the regulatory effects of cellular repressor of E1A-stimulated gene (CREG) on autophagy and polarization of alveolar macrophages in sepsis-induced acute respiratory distress syndrome (ARDS) and its clinical value.
METHODS: 1) Cell experiment: Mouse monocyte/macrophage cell line RAW264.7 was cultured in vitro. Cells in logarithmic growth phase were induced to differentiate into alveolar macrophages. The alveolar macrophages were divided into four groups: the blank control group was cultured with complete medium only; the lipopolysaccharide (LPS) group was stimulated with 5 mg/L LPS for 24 hours to establish the sepsis-induced ARDS model; the CREG overexpression group was transfected with 2 mg CREG overexpression plasmid pLNCX2-CREG for 6 hours, followed by 5 mg/L LPS stimulation for 24 hours; the CREG interference group was transfected with 2 μg CREG interference plasmid pSM2-siCREG for 6 hours, followed by 5 mg/L LPS stimulation for 24 hours. Western blotting was used to detect the expression of autophagy markers [autophagy initiation key protein Beclin1, microtubule-associated protein 1 light chain 3 (LC3), and autophagic substrate protein p62]. Flow cytometry was used to detect the expression of macrophage polarization markers [M1-type characteristic marker cluster of differentiation 86 (CD86) and M2-type characteristic marker CD206]. 2) Clinical trial: A prospective case-control study was conducted in patients with sepsis admitted to the respiratory intensive care unit of The First Affiliated Hospital of Hebei North University from January to December 2024. Patients were divided into sepsis with ARDS group and sepsis without ARDS group based on whether they developed ARDS within 72 hours after enrollment. In addition, healthy volunteers who underwent health check-ups at the hospital during the same period were selected as the controls. Demographic data including gender, age, Acute Physiology And Chronic Health Evaluation II (APACHE II) score, oxygenation index (PaO2/FiO2), and laboratory parameters were collected for each group, as well as the sites of infection for the septic patients. Serum levels of CREG and inflammatory markers [interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), procalcitonin (PCT), and C-reactive protein (CRP)] were measured using enzyme-linked immunosorbent assay (ELISA). The differences in the above indicators were compared among groups. Multivariate Logistic regression analysis was used to identify independent influencing factors for sepsis complicated with ARDS. Receiver operator characteristic curve (ROC curve) was plotted to evaluate the predictive value of CREG for sepsis complicated with ARDS.
RESULTS: 1) Cell experiment results: Compared with the blank control group, the expressions of Beclin1, LC3-II/LC3-I ratio, and CD206 were decreased in each LPS group [Beclin1 protein (Beclin1/β-actin): 0.32±0.05 vs. 0.87±0.09, LC3-II/LC3-I ratio: 0.41±0.06 vs. 1.24±0.11, CD206: (27.14±3.52)% vs. (51.78±5.91)%, all P<0.05], while p62 and CD86 expressions were increased [p62 protein (p62/β-actin): 1.58±0.13 vs. 0.53±0.07, CD86: (38.35±4.67)% vs. (18.26±3.24)%, both P<0.05]. CREG overexpression significantly improved the above autophagy and polarization indicators, whereas CREG interference further exacerbated these indicators (all P<0.05). 2) Clinical trial results: Ultimately, 40 patients were included in the sepsis with ARDS group, 60 in the sepsis without ARDS group, and 20 in the healthy control group. There were no statistically significant differences in gender, age among the three groups, nor in the distribution of infection sites between the sepsis with ARDS and sepsis without ARDS groups (all P>0.05). Compared with the healthy control group, the patients with sepsis showed aggravated systemic inflammatory burden. Compared with the sepsis without ARDS group, the sepsis with ARDS group exhibited more severe disease, with lower PaO2/FiO2 and CREG levels, and higher levels of inflammatory markers (all P<0.05). As APACHE II score increased, serum CREG levels decreased progressively while inflammatory marker levels increased progressively. Multivariate Logistic regression analysis showed that elevated APACHE II score and inflammatory markers were independent risk factors for sepsis complicated with ARDS [all odds ratio (OR) >1, all P<0.05], while elevated CREG was a protective factor [OR=0.385, 95% confidence interval (95%CI) was 0.344-0.432, P=0.015]. ROC curve analysis showed that the area under the ROC curve (AUC) of CREG for predicting sepsis complicated with ARDS was 0.806 (95%CI was 0.713-0.899); at the optimal cut-off value of 7.85 μg/L, the sensitivity was 71.43% and the specificity was 78.57%.
CONCLUSIONS: CREG exerts a protective role in sepsis-induced ARDS by positively regulating alveolar macrophage autophagy activity and correcting M1/M2 polarization imbalance. Elevated serum CREG is a protective factor for sepsis complicated with ARDS and has early predictive value for sepsis-induced ARDS.
参考来源
- Cao L, Zou F, Zhang C, et al. [Study on cellular repressor of E1A-stimulated genes regulating autophagy and polarization of alveolar macrophages in sepsis-induced acute respiratory distress syndrome and its clinical value]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42563678. doi:10.3760/cma.j.cn121430-20251021-00518
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。